Tag: IDE
Second US clinical study for Alucent Biomedical’s AlucentNVS technology receives US...
At the beginning of November 2023, Alucent Biomedical announced via press release that it has received a US Food and Drug Administration (FDA) investigational...
First subjects enrolled in US clinical trial for VenoStent
VenoStent has announced that the first subjects have been enrolled in the SAVE-FistulaS clinical trial, which will take place at two different sites across...